Free Trial

Rigel Pharmaceuticals (RIGL) SEC Filings & 10K Form

Rigel Pharmaceuticals logo
$20.94 +0.82 (+4.08%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$20.62 -0.32 (-1.53%)
As of 05/21/2025 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Rigel Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/17/2025
8:35 AM
BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/10/2025
3:06 PM
Rigel Pharmaceuticals (Filer)
Form DEF 14A
04/10/2025
3:07 PM
Rigel Pharmaceuticals (Filer)
Form DEFA14A
04/10/2025
3:10 PM
Rigel Pharmaceuticals (Filer)
Form ARS
03/27/2025
8:16 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
7:55 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:41 PM
Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/10/2025
4:42 PM
Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:22 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:18 PM
ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/07/2025
12:42 PM
Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/06/2025
7:26 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
2:40 PM
Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:41 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:43 PM
Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:58 PM
Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/04/2025
3:39 PM
Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:30 PM
Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:20 PM
Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:21 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:45 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:49 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:38 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
7:15 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
8:33 AM
Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G
11/07/2024
3:22 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The DOJ Just Said Your Money Isn’t Yours (Ad)

What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.

Get your free guide now by clicking here >>
09/19/2024
3:01 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
7:36 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:33 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:30 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2024
11:15 PM
Rigel Pharmaceuticals (Filer)
Form EFFECT
06/27/2024
3:31 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:45 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:19 PM
Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:21 PM
MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:21 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:06 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RIGL) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners